Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer

Biochemical and Biophysical Research Communications

Volumn 416, Issue 3-4, 2011, Pages 372-378

  Li, Wenjuan ^a   Zhao, Li ^a   Zang, Wen ^a   Liu, Zhifang ^a   Chen, Long ^a   Liu, Tiantian ^a   Xu, Dawei ^a,b   Jia, Jihui ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epigenetics; Gastric cancer; Histone demethylase; JMJD2B; Tumorigenesis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; HISTONE DEMETHYLASE; HISTONE DEMETHYLASE 2B; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CANCER TISSUE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; GENE KNOCKDOWN TECHNIQUES; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MICE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84855876194     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.045     Document Type: Article

References (27)

1. Zheng L., Wang L., Ajani J., et al. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004, 7:61-77.
2. Vogiatzi P., Vindigni C., Roviello F., et al. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J. Cell. Physiol. 2007, 211:287-295.
3. Correa P., Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007, 133:659-672.
4. Li W., Ge Z., Liu C., et al. CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin. Cancer Res. 2008, 14:3722-3728.
5. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
6. Shi Y., Whetstine J.R. Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 2007, 25:1-14.
7. Whetstine J.R., Nottke A., Lan F., et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006, 125:467-481.
8. Fodor B.D., Kubicek S., Yonezawa M., et al. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev. 2006, 20:1557-1562.
9. Shi L., Sun L., Li Q., et al. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc. Natl. Acad. Sci. USA 2011, 108:7541-7546.
10. Zeng J., Ge Z., Wang L., et al. The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology 2010, 138:981-992.
11. Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat. Rev. Genet. 2007, 8:829-833.
12. Cloos P.A., Christensen J., Agger K., et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 2006, 442:307-311.
13. Xiang Y., Zhu Z., Han G., et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl. Acad. Sci. USA 2007, 104:19226-19231.
14. Yamane K., Tateishi K., Klose R.J., et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell 2007, 25:801-812.
15. Yang J., Jubb A.M., Pike L., et al. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res. 2010, 70:6456-6466.
16. Wissmann M., Yin N., Muller J.M., et al. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol. 2007, 9:347-353.
17. Yang Z.Q., Imoto I., Fukuda Y., et al. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res. 2000, 60:4735-4739.
18. Beyer S., Kristensen M.M., Jensen K.S., et al. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem. 2008, 283:36542-36552.
19. Kawazu M., Saso K., Tong K.I., et al. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One 2011, 6:e17830.
20. Li W., Zeng J., Li Q., et al. Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer. Mol. Cancer 2010, 9:132.
21. Ge Z., Li W., Wang N., et al. Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase. FASEB J. 2010, 24:579-586.
22. Sheu J.J., Guan B., Choi J.H., et al. Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability. J. Biol. Chem. 2010, 285:38260-38269.
23. Vidanes G.M., Bonilla C.Y., Toczyski D.P. Complicated tails: histone modifications and the DNA damage response. Cell 2005, 121:973-976.
24. Burma S., Chen B.P., Murphy M., et al. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 2001, 276:42462-42467.
25. Rogakou E.P., Pilch D.R., Orr A.H., et al. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
26. Shin S., Janknecht R. Diversity within the JMJD2 histone demethylase family. Biochem. Biophys. Res. Commun. 2007, 353:973-977.
27. Soutoglou E., Misteli T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science 2008, 320:1507-1510.